| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.74B | 30.95B | 27.91B | 24.25B | 21.23B | 24.24B |
| Gross Profit | 13.18B | 12.86B | 11.92B | 10.32B | 9.25B | 7.79B |
| EBITDA | 7.07B | 6.99B | 6.35B | 5.22B | 4.80B | 4.06B |
| Net Income | 3.54B | 3.55B | 3.26B | 2.74B | 2.36B | 1.82B |
Balance Sheet | ||||||
| Total Assets | 34.67B | 35.59B | 31.30B | 25.19B | 22.79B | 21.14B |
| Cash, Cash Equivalents and Short-Term Investments | 15.22B | 14.96B | 13.51B | 9.43B | 9.32B | 9.98B |
| Total Debt | 1.86M | 0.00 | 0.00 | 11.84M | 48.91M | 93.53M |
| Total Liabilities | 9.79B | 10.99B | 9.65B | 7.66B | 7.60B | 6.75B |
| Stockholders Equity | 21.60B | 21.38B | 19.05B | 15.33B | 13.25B | 12.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.87B | 5.16B | 1.30B | 3.09B | 2.87B |
| Operating Cash Flow | 0.00 | 5.00B | 6.48B | 2.57B | 3.86B | 3.30B |
| Investing Cash Flow | 0.00 | -1.98B | -1.39B | -1.33B | -1.70B | -406.19M |
| Financing Cash Flow | 0.00 | -1.56B | -1.02B | -1.13B | -2.53B | -407.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥56.69B | 14.49 | ― | 2.59% | 11.92% | 7.75% | |
73 Outperform | $51.19B | 15.86 | 18.34% | 3.05% | 4.89% | 4.85% | |
72 Outperform | $64.28B | 15.03 | 15.02% | 3.24% | 9.98% | 13.52% | |
72 Outperform | ¥38.06B | 16.94 | ― | 2.64% | 21.47% | 30.64% | |
71 Outperform | ¥76.71B | 11.95 | ― | 3.41% | 5.28% | 28.90% | |
68 Neutral | ¥37.29B | 10.34 | ― | 3.40% | <0.01% | -17.60% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |